The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
Share
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Inside the Army’s FUZE Model for Rapid Tech Deployment
FUZE Director Matthew Willis explains how the Army is using a venture-style investment model to move emerging technologies from prototype to the field faster.
10m listen -
CDC’s AI Strategy Embraces Speed, Flexibility
CDC’s Chief AI Officer Travis Hoppe shares how the agency is aligning cutting-edge tools with federal standards and mission needs.
13m watch -
Marine Warfighting Lab Turns Lessons from Ukraine into Future Strategy
The Marine Corps Warfighting Laboratory uses wargaming and simulation to analyze threats, test capabilities and prepare for future conflicts.
12m listen -
Former DOL CISO on the Importance of Building Your Network
Paul Blahusch discusses leveraging your network and the power of pivoting.
7m watch
